Pricing Log in Create free account

Azora Therapeutics, Inc. (AZR) vs BioVie Inc. (BIVI)

Azora Therapeutics, Inc. and BioVie Inc. are both Biotechnology companies. Azora Therapeutics, Inc. and BioVie Inc. are of similar size ($10.3M and $9.7M). Across the 8 metrics below, Azora Therapeutics, Inc. leads on 5 and BioVie Inc. on 3.

Valuation

Metric AZR BIVI Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B n/m 0.85 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.19 n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (433.06%) (260.33%) (34.89%)
Free cash flow yield (62.39%) (216.99%) (24.52%)

Profitability

Metric AZR BIVI Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 352.60% (151.06%) (50.12%)
Return on assets (322.10%) (123.51%) (45.60%)
Return on invested capital 0.00% (1,095.01%) 0.00%

Growth

Metric AZR BIVI Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) 82.46% 74.83% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AZR BIVI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.63 3.59 4.89
Net debt to EBITDA 0.75 0.40 1.01

Dividend

Metric AZR BIVI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AZR BIVI Biotechnology median
Market cap 9.74m 10.32m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack